Fireeye Inc (FEYE) 15.23 $FEYE InvestorsObserver

New Post Public Reply Private Reply Replies (0) Message Board

Sep 3, 2016 at 9:13 PM

Fireeye Inc (FEYE) 15.23 $FEYE

InvestorsObserver releases covered-call reports for 3D Systems, General Motors, BP, First Majestic Silver and FireEye
PR Newswire - Tue Aug 30, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for AG, BP, DDD, FEYE, and GM.
FEYE: 15.23 (+0.04), AG: 12.37 (+0.58), DDD: 14.92 (+0.71), GM: 32.16 (+0.36), BP: 34.50 (+0.84)

Application Software Stocks under Review -- Oracle, FireEye, salesforce.com, and Adobe Systems
PR Newswire - Fri Aug 26, 6:30AM CDT
Stock-Callers.com's focus today is on these four Application Software equities: Oracle Corp. (NYSE: ORCL), FireEye Inc. (NASDAQ: FEYE), salesforce.com inc. (NYSE: CRM), and Adobe Systems Inc. (NASDAQ: ADBE). These stocks belong in the Technology sector which was quiet ahead of the opening bell on Thursday, August 25, 2016. As per NASDAQ, shares of tech companies in the S&P 500 were unchanged in early trading. Learn more about these stocks by downloading their free research reports in PDF format at:
FEYE: 15.23 (+0.04), ADBE: 103.57 (+0.67), ORCL: 41.25 (+0.09), CRM: 75.10 (-0.81)

Bear of the Day: Palo Alto Networks (PANW)
Jeremy Mullin - ZACKS - Fri Aug 12, 6:00AM CDT
Bear of the Day: Palo Alto Networks (PANW)
FEYE: 15.23 (+0.04), ARRS: 28.45 (+0.19), CYBR: 55.38 (+1.75), PANW: 145.18 (+4.52)

Freeport-McMoRan trade offers a 10% return in 192 days, or find similar option trades on SM Energy Company, Sotheby's, FireEye, and Amazon.com
PR Newswire - Tue Aug 09, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for AMZN, BID, FCX, FEYE, and SM.
BID: 40.16 (+0.66), AMZN: 772.44 (+1.82), FEYE: 15.23 (+0.04), FCX: 10.48 (+0.13), SM: 38.85 (+1.29)

Evolving Cyber Security Protection Services Mega-Market Growth Fueled By Brands' Increasing Vulnerability
PR Newswire - Tue Aug 09, 7:30AM CDT
Cyber security products and services continues to be one of the more intriguing developing industries across the globe as more companies are allocating dollars towards protecting their image and assets online. The quickly maturing Cyber Security Sector forecasted to top $200 Billion within 5 Years as Leading Brands rush to spend capital on digital and online protection services.
FEYE: 15.23 (+0.04), EMC: 28.77 (-0.09), INTC: 36.08 (+0.06), CHKP: 77.98 (+1.02)

FireEye Announces Participation in Upcoming Investor Conferences
Marketwired - Mon Aug 08, 7:41AM CDT
MILPITAS, CA--(Marketwired - Aug 8, 2016) - FireEye, Inc. (NASDAQ: FEYE), the leader at stopping today's advanced cyber attacks, today announced participation in upcoming conferences.
FEYE: 15.23 (+0.04)

FireEye (FEYE) Q2 Loss Lower than Expected but Stock Down
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 8:46AM CDT
Shares of FireEye Inc. (FEYE) lost over 17% in afterhours trading yesterday after the company's second-quarter 2016 revenues and billion fell short of management's guidance.
FEYE: 15.23 (+0.04), PANW: 145.18 (+4.52), JNPR: 23.41 (+0.10), PAYC: 52.10 (+0.75)

FireEye Inc. (FEYE) Sees Shares Tank After Posting Q2 Earnings Beat, Revenue Miss
Adam Clark - Zacks Investment Research - Thu Aug 04, 4:56PM CDT
FireEye Inc. reported its second quarter 2016 earnings Thursday after the bell, posting a less-than-expected loss despite a miss on revenue estimates.
FEYE: 15.23 (+0.04)

FireEye Reports Second Quarter 2016 Results
Marketwire Canada - Thu Aug 04, 3:01PM CDT
Improved Operating Margins Result in Loss per Share Above Expectations
FEYE: 15.23 (+0.04)

Look at Aug 4 Internet Stocks Q2 Earnings: LNKD, FEYE & More
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 8:38AM CDT
Among the companies slated to report this week, let's find out what's in the cards for these five Internet stocks, all of which are scheduled to report second-quarter 2016 results on Aug 4.
FEYE: 15.23 (+0.04), LNKD: 192.80 (+0.07), ZG: 34.60 (+0.55), MKTO: 35.25 (+0.46), SSTK: 58.92 (+1.14)

FireEye (FEYE): What's in Store for the Stock in Q2 Earnings?
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:03AM CDT
FireEye Inc. (FEYE) is set to report second-quarter 2016 results on Aug 4.
FEYE: 15.23 (+0.04), QLYS: 35.53 (+0.48), PANW: 145.18 (+4.52), CTL: 27.94 (+0.20)

Designer Brand With Millions in Revenue Engages IP Risk & Cyber Security Company as Top Brands Identify Need to Protect Assets & Online Brand Reputation
PR Newswire - Tue Aug 02, 7:45AM CDT
IP Risk Control and Cyber Security protection is quickly becoming the top priority for many companies to protect brand reputation, prevent financial loss and guard against intellectual property risks. As the benefits of a more digital society become more evident, so do the risks on the other side of the spectrum. Because of this, according to a recent Forbes Article, spending on cyber security and online brand protection is forecasted to top $170 Billion by 2020.
FEYE: 15.23 (+0.04), CYBR: 55.38 (+1.75), MGT: 3.33 (+0.12), SYMC: 24.28 (+0.13)

Learn how to target a 12% return on Exelixis, or get option-trade ideas on FireEye, Baidu, Marathon Petroleum Corporation and First Solar or any stock you choose
PR Newswire - Fri Jul 29, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for BIDU, EXEL, FEYE, FSLR, and MPC.
FSLR: 38.18 (-0.26), FEYE: 15.23 (+0.04), BIDU: 177.78 (+1.23), MPC: 42.32 (+0.41), EXEL: 11.54 (+0.19)

Here's Why FireEye (FEYE) Stock Is Soaring Today
Ryan McQueeney - Zacks Investment Research - Thu Jul 28, 2:36PM CDT
Shares of network security company FireEye (FEYE) are up nearly 11.5% on Thursday after new speculation about a possible takeover, as well as the widely publicized DNC hacks bringing cybersecurity into the national spotlight once again.
FEYE: 15.23 (+0.04), SYMC: 24.28 (+0.13)

FireEye Wins NYSE Governance Services 2016 Leadership Award
Marketwire Canada - Fri Jun 24, 7:00AM CDT
Company Honored as Best In-House Legal Team for Corporate Governance at a Small to Mid-Cap Company
FEYE: 15.23 (+0.04)

Symantec (SYMC) Stock Up over 20% Recently: Here's Why
Zacks Equity Research - Zacks Investment Research - Thu Jun 23, 7:51AM CDT
Shares of Symantec Corporation (SYMC) soared significantly over the last 10 days.
FEYE: 15.23 (+0.04), PANW: 145.18 (+4.52), CHKP: 77.98 (+1.02), SYMC: 24.28 (+0.13)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...